Portal de Periódicos da CAPES

Assessment of SARS-CoV-2 neutralizing antibody titers in breastmilk from convalescent and vaccinated mothers

2023; Cell Press; Volume: 26; Issue: 6 Linguagem: Inglês

10.1016/j.isci.2023.106802

2589-0042

Christine Bäuerl, João Zulaica, Luciana Rusu, Alicia Rodríguez-Moreno, Francisco J. Pérez‐Cano, Carles Lerín, Desirée Mena‐Tudela, Laia Aguilar‐Camprubí, Anna Parra‐Llorca, Cecilia Martínez‐Costa, Ron Geller, María Carmen Collado,

Vaccine Coverage and Hesitancy

Breastmilk contains antibodies that could protect breastfed infants from infections. In this work, we examined if antibodies in breastmilk could neutralize SARS-CoV-2 in 84 breastmilk samples from women that were either vaccinated (Comirnaty, mRNA-1273, or ChAdOx1), infected with SARS-CoV-2, or both infected and vaccinated. The neutralization capacity of these sera was tested using pseudotyped vesicular stomatitis virus carrying either the Wuhan-Hu-1, Delta, or BA.1 Omicron spike proteins. We found that natural infection resulted in higher neutralizing titers and that neutralization correlated positively with levels of immunoglobulin A in breastmilk. In addition, significant differences in the capacity to produce neutralizing antibodies were observed between both mRNA-based vaccines and the adenovirus-vectored ChAdOx1 COVID-19 vaccine. Overall, our results indicate that breastmilk from naturally infected women or those vaccinated with mRNA-based vaccines contains SARS-CoV-2 neutralizing antibodies that could potentially provide protection to breastfed infants from infection.